Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655681 · ClinicalTrials.gov registry record · NA
Prevention of Post Operative Bone Loss in Children
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00655681 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 24 participants.
The verdict
NCT00655681, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Hypothesis: one-dose pamidronate will prevent post-operative bone loss in children at risk for low bone density Plan: children with chronic disease such as CP, spina bifida, etc. will be recruited pre operatively and studied with DXA scan. After surgery, children will be randomized to receive either pamidronate or saline. Repeat DXA scan will determine bone lost after end of immobilization or nonweightbearing.
Interventions
- OTHER saline
- DRUG pamidronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00655681
The ClinicalTrials.gov registry entry for NCT00655681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which saline is the first listed.
NCT00655681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00655681 about?
NCT00655681 is a clinical study titled "Prevention of Post Operative Bone Loss in Children". Hypothesis: one-dose pamidronate will prevent post-operative bone loss in children at risk for low bone density Plan: children with chronic disease such as CP, spina bifida, etc. will be recruited pre operatively and studied with DXA scan. After surgery, children will be randomized to receive eithe...
What is the current status of trial NCT00655681?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2007-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00655681?
The interventions under investigation include: saline (OTHER), pamidronate (DRUG).
Who is sponsoring clinical trial NCT00655681?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.